In recent years, antibody-based immunotherapy seems to become a new treatment option for oncological patients. Among all antibody isotypes, IgG antibody is the most widely studied. But there are many deficiencies of IgG therapeutic antibody that limit its application. Therefore, non-IgG antibodies are receiving more and more attention in cancer immunotherapy. Based on years of experience and construction, Creative Biolabs has gained a good reputation in antibody development service. Here we are proud to provide a wide range of non-IgG therapeutic antibodies services to universal customers.